“Patients With Atopic Dermatitis Using Oral Contraceptive Pills or Hormone Replacement Therapy: Long-Term Safety of Upadacitinib for Major Adverse Cardiovascular Events, Venous Thromboembolism, or Malignancy (Excluding Nonmelanoma Skin Cancer)”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s613. https://doi.org/10.25251/stfagt72.